Published in Biotechnol Prog on March 04, 2011
Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors. Tissue Eng Part C Methods (2012) 1.11
Combining hypoxia and bioreactor hydrodynamics boosts induced pluripotent stem cell differentiation towards cardiomyocytes. Stem Cell Rev (2014) 0.80
Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells. Stem Cell Res (2015) 0.78
Theoretical and Practical Issues That Are Relevant When Scaling Up hMSC Microcarrier Production Processes. Stem Cells Int (2016) 0.75
Mathematical model of influenza A virus production in large-scale microcarrier culture. Biotechnol Bioeng (2005) 1.55
Metabolic effects of influenza virus infection in cultured animal cells: Intra- and extracellular metabolite profiling. BMC Syst Biol (2010) 1.36
Continuous cell lines as a production system for influenza vaccines. Expert Rev Vaccines (2009) 1.14
Simultaneous extraction of several metabolites of energy metabolism and related substances in mammalian cells: optimization using experimental design. Anal Biochem (2007) 1.13
Glycan analysis in cell culture-based influenza vaccine production: influence of host cell line and virus strain on the glycosylation pattern of viral hemagglutinin. Vaccine (2009) 1.04
Quantitative analysis of cellular proteome alterations in human influenza A virus-infected mammalian cell lines. Proteomics (2009) 1.04
PPARα and fatty acid oxidation mediate glucocorticoid resistance in chronic lymphocytic leukemia. Blood (2013) 1.03
Growth behavior of number distributed adherent MDCK cells for optimization in microcarrier cultures. Biotechnol Prog (2009) 1.03
Impact of stents and flow diverters on hemodynamics in idealized aneurysm models. J Biomech Eng (2011) 1.00
Modeling the intracellular dynamics of influenza virus replication to understand the control of viral RNA synthesis. J Virol (2012) 1.00
Substitution of glutamine by pyruvate to reduce ammonia formation and growth inhibition of mammalian cells. Biotechnol Prog (2005) 0.97
High yields of influenza A virus in Madin-Darby canine kidney cells are promoted by an insufficient interferon-induced antiviral state. J Gen Virol (2010) 0.96
Metagenome and metaproteome analyses of microbial communities in mesophilic biogas-producing anaerobic batch fermentations indicate concerted plant carbohydrate degradation. Syst Appl Microbiol (2013) 0.95
Neuraminidase activity assays for monitoring MDCK cell culture derived influenza virus. J Virol Methods (2004) 0.95
Adaption of a fragment analysis technique to an automated high-throughput multicapillary electrophoresis device for the precise qualitative and quantitative characterization of microbial communities. Electrophoresis (2002) 0.94
Monitoring influenza virus content in vaccine production: precise assays for the quantitation of hemagglutination and neuraminidase activity. Biologicals (2008) 0.94
Real-time RT-qPCR assay for the analysis of human influenza A virus transcription and replication dynamics. J Virol Methods (2010) 0.93
Characterization of a three bacteria mixed culture in a chemostat: evaluation and application of a quantitative terminal-restriction fragment length polymorphism (T-RFLP) analysis for absolute and species specific cell enumeration. Biotechnol Bioeng (2007) 0.92
The MetaProteomeAnalyzer: a powerful open-source software suite for metaproteomics data analysis and interpretation. J Proteome Res (2015) 0.89
Multiscale modeling of influenza A virus infection supports the development of direct-acting antivirals. PLoS Comput Biol (2013) 0.89
Searching for a needle in a stack of needles: challenges in metaproteomics data analysis. Mol Biosyst (2013) 0.89
Continuous influenza virus production in cell culture shows a periodic accumulation of defective interfering particles. PLoS One (2013) 0.89
Comparison of metabolic flux distributions for MDCK cell growth in glutamine- and pyruvate-containing media. Biotechnol Prog (2008) 0.88
Metabolic flux model for an anchorage-dependent MDCK cell line: characteristic growth phases and minimum substrate consumption flux distribution. Biotechnol Bioeng (2008) 0.88
Enhancing the enantioselectivity of an epoxide hydrolase by directed evolution. Org Lett (2004) 0.88
N-glycan analysis by CGE-LIF: profiling influenza A virus hemagglutinin N-glycosylation during vaccine production. Electrophoresis (2008) 0.88
Cerebral blood flow in a healthy Circle of Willis and two intracranial aneurysms: computational fluid dynamics versus four-dimensional phase-contrast magnetic resonance imaging. J Biomech Eng (2014) 0.87
Impact of defective interfering particles on virus replication and antiviral host response in cell culture-based influenza vaccine production. Appl Microbiol Biotechnol (2014) 0.86
A flow cytometric method for viability assessment of Staphylococcus aureus and Burkholderia cepacia in mixed culture. Cytometry A (2012) 0.86
High-performance anion-exchange chromatography using on-line electrolytic eluent generation for the determination of more than 25 intermediates from energy metabolism of mammalian cells in culture. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.86
Impact of host cell line adaptation on quasispecies composition and glycosylation of influenza A virus hemagglutinin. PLoS One (2011) 0.85
Metaproteome analysis to determine the metabolically active part of a thermophilic microbial community producing biogas from agricultural biomass. Can J Microbiol (2012) 0.85
Toward animal cell culture-based influenza vaccine design: viral hemagglutinin N-glycosylation markedly impacts immunogenicity. J Immunol (2012) 0.85
Metaproteome analysis of sewage sludge from membrane bioreactors. Proteomics (2011) 0.84
MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation. Appl Microbiol Biotechnol (2010) 0.84
Effects of a recombinant gene expression on ColE1-like plasmid segregation in Escherichia coli. BMC Biotechnol (2011) 0.84
Purification of cell culture-derived human influenza A virus by size-exclusion and anion-exchange chromatography. Biotechnol Bioeng (2007) 0.84
Virus-host cell interactions in vaccine production cell lines infected with different human influenza A virus variants: a proteomic approach. J Proteomics (2010) 0.84
Downstream processing of cell culture-derived virus particles. Expert Rev Vaccines (2011) 0.84
Trypsin promotes efficient influenza vaccine production in MDCK cells by interfering with the antiviral host response. Appl Microbiol Biotechnol (2011) 0.84
Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cells. BMC Biotechnol (2012) 0.83
Realistic virtual intracranial stenting and computational fluid dynamics for treatment analysis. J Biomech (2012) 0.83
Harvesting and concentration of human influenza A virus produced in serum-free mammalian cell culture for the production of vaccines. Biotechnol Bioeng (2007) 0.83
Proteome analysis of virus-host cell interaction: rabies virus replication in Vero cells in two different media. Appl Microbiol Biotechnol (2013) 0.81
Amino acid analysis in mammalian cell culture media containing serum and high glucose concentrations by anion exchange chromatography and integrated pulsed amperometric detection. Anal Biochem (2004) 0.81
Recommendations for accurate numerical blood flow simulations of stented intracranial aneurysms. Biomed Tech (Berl) (2013) 0.80
Flow cytometric monitoring of influenza A virus infection in MDCK cells during vaccine production. BMC Biotechnol (2008) 0.80
glyXalign: high-throughput migration time alignment preprocessing of electrophoretic data retrieved via multiplexed capillary gel electrophoresis with laser-induced fluorescence detection-based glycoprofiling. Electrophoresis (2013) 0.79
Development of a high-throughput glycoanalysis method for the characterization of oligosaccharides in human milk utilizing multiplexed capillary gel electrophoresis with laser-induced fluorescence detection. Electrophoresis (2013) 0.79
Efficient influenza B virus propagation due to deficient interferon-induced antiviral activity in MDCK cells. Vaccine (2011) 0.79
Community shifts in a well-operating agricultural biogas plant: how process variations are handled by the microbiome. Appl Microbiol Biotechnol (2015) 0.79
Proteomic tracking and analysis of a bacterial mixed culture. Proteomics (2012) 0.79
Characterization of flow conditions in 2 L and 20 L wave bioreactors using computational fluid dynamics. Biotechnol Prog (2010) 0.79
Coexistence in the chemostat as a result of metabolic by-products. J Math Biol (2006) 0.78
Identification of growth phases and influencing factors in cultivations with AGE1.HN cells using set-based methods. PLoS One (2013) 0.78
Segregated mathematical model for growth of anchorage-dependent MDCK cells in microcarrier culture. Biotechnol Prog (2008) 0.78
Atmospheric pressure free liquid infrared MALDI mass spectrometry: toward a combined ESI/ MALDI-liquid chromatography interface. Anal Chem (2009) 0.78
Species-specific viability analysis of Pseudomonas aeruginosa, Burkholderia cepacia and Staphylococcus aureus in mixed culture by flow cytometry. BMC Microbiol (2014) 0.78
Flow cytometric viability assessment of lactic acid bacteria starter cultures produced by fluidized bed drying. Appl Microbiol Biotechnol (2014) 0.78
Interspecies effects in a ceftazidime-treated mixed culture of Pseudomonas aeruginosa, Burkholderia cepacia and Staphylococcus aureus: analysis at the single-species level. J Antimicrob Chemother (2010) 0.77
Capture of cell culture-derived influenza virus by lectins: strain independent, but host cell dependent. J Virol Methods (2008) 0.77
Bioreactor concepts for cell culture-based viral vaccine production. Expert Rev Vaccines (2015) 0.77
CAP, a new human suspension cell line for influenza virus production. Appl Microbiol Biotechnol (2012) 0.77
A novel concept combining experimental and mathematical analysis for the identification of unknown interspecies effects in a mixed culture. Biotechnol Bioeng (2011) 0.77
Impact of cultivation conditions on N-glycosylation of influenza virus a hemagglutinin produced in MDCK cell culture. Biotechnol Bioeng (2013) 0.77
How can measurement, monitoring, modeling and control advance cell culture in industrial biotechnology? Biotechnol J (2012) 0.76
N-Glycosylation Fingerprinting of Viral Glycoproteins by xCGE-LIF. Methods Mol Biol (2015) 0.76
The avian cell line AGE1.CR.pIX characterized by metabolic flux analysis. BMC Biotechnol (2014) 0.76
Purification of cell culture-derived modified vaccinia ankara virus by pseudo-affinity membrane adsorbers and hydrophobic interaction chromatography. Biotechnol Bioeng (2010) 0.76
Capturing of cell culture-derived modified Vaccinia Ankara virus by ion exchange and pseudo-affinity membrane adsorbers. Biotechnol Bioeng (2010) 0.75
Purification of cell culture-derived influenza virus A/Puerto Rico/8/34 by membrane-based immobilized metal affinity chromatography. J Virol Methods (2009) 0.75
Profiling of external metabolites during production of hantavirus nucleocapsid protein with recombinant Saccharomyces cerevisiae. Biotechnol Lett (2007) 0.75
Experimental validation of numerical simulations on a cerebral aneurysm phantom model. Interv Med Appl Sci (2012) 0.75
MPA Portable: a Stand-alone Software Package for Analyzing Metaproteome Samples on the Go. Anal Chem (2017) 0.75
Vaccine production: upstream processing with adherent or suspension cell lines. Methods Mol Biol (2014) 0.75
Sulfated membrane adsorbers for economic pseudo-affinity capture of influenza virus particles. Biotechnol Bioeng (2009) 0.75